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Results: 
 
• Sensitivity (N = 30 normal samples)  
 D = Limit of detection (%) = 3 * σ 
 Q = Limit of quantification (%) = 10 * σ  
The background of 30 normal samples allowed us to define 
the sensitivity of the method. As shown in the table, the method can detect GPI deficient    
clones as low as 0,01 %.         
 
• Interferences by eosinophils and immatures granulocytes  
Samples with eosinophilia or immature granulocytes were tested (N=30 for each category) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Intra-assay precision 
 
 
 
 
 
 
 
 
 
• Overall linearity of  
        cytometric measures 
  
   
 
 
           High range: dilution of CD3+ T cells                   Low range: dilution of CD34+ cells 
 
• Combined uncertainty of  measurement uc (neutrophil analysis): based on 15 external quality controls (UKNEQAS), and computed from  
 our average bias and the group dispersion with regards to the median. 
 
• Stability 
         Typing must be done within 2  days for WBC analysis and within 7 days for  RBC, to avoid antigen alteration. Samples must be stored at 4°C. 
         Stained samples must be analyzed at 1 to 3 hours after fixation.  
 
Conclusion: 
The detection of PNH by flow cytometry may be validated according to ISO15189 standard, when using published international guidelines. The estimation of linearity should be completed with dilutions of a sample with a large PNH 
clone. 
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Method: 
The panel used by Borowitz et al. includes  
Flaer AF488 - CD45 PerCP - CD33 PC7 - 
CD15 AF647 - CD 24PE - CD 14 AH7 
provides us a sequence of analysis that 
discriminates neutrophils from monocytes 
and highlights GPI-deficient cells with 2 
parameters:  
 
 Plot 4: GPI-deficient neutrophils are in 
the lower left corner  (CD 24 - Flaer -) 
 
 Plot 5 : GPI-deficient monocytes are in 
the left lower corner (CD 14 - Flaer -) 
 
Neutrophils  Monocytes Red Blood Cells 
D = 0,006 
 
Q = 0,021 
D = 0,009 
 
Q = 0,028 
D = 0,004 
 
Q = 0,012 
The estimation of detection limit 
(left) and analysis of cytograms 
(right) show that eosinophils don’t 
cause interference in the PNH 
assay. 
Immature Granulocytes (IG) can 
induce many interferences if gating 
is not precise enough (plot A & B).  
However, even after gating off IG, 
some false GPI deficient events are 
detected (plot C & D).  
GPI deficient events  (%) Neutrophils Monocytes RBC 
Mean 10,59 9,75 11,24 
Standard deviation 0,15 0,42 0,11 
Coefficient of variation (%) 1,38 4,28 1,02 
y = 86,479x + 0,3406 
R² = 0,9997 
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Background: 
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and acquired disease due to a mutation, in hematopoietic stem cells, of phosphatidylinositol glycan complementation class A (PIG-A) gene 
leading to a partial or total deficiency of the enzyme involved in the synthesis of glycosylphosphatidylinositol (GPI). This prevents the binding of many proteins linked to the cell membrane of 
erythrocytes and leucocytes, such as CD 55 and CD 59. Without these 2 proteins on the red blood cells (RBC) surface, RBC are more sensitive to the lytic action of the complement system, 
which leads to  intravascular haemolysis.  
Diagnostic of PNH is carried out by flow cytometry (BD FACSCANTO II). In this study, we have followed the guidelines established by Borowitz et al. (Cytometry B, 78B-211, 2010). The 
guidelines include a first panel of antibodies to identify neutrophils and monocytes and a second panel directed against GPI-linked proteins (CD 24 and CD 14). Besides antibodies, the protocol 
uses an inactive variant of aerolysin (FLAER) which is directly linked to GPI anchor. When GPI-deficient leucocytes are detected, an additional panel is used to quantify GPI-deficient RBC, using 
glycophorin A gating and CD59. The validation of PNH detection was undertaken in accordance to ISO15189 standard and included the following parameters: intra-assay precision, bias, 
uncertainty of measurement, limits of detection and quantification (sensitivity), interference analysis, overall linearity of flow-cytometric measures and sample stability. 
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